On 5 February 2026, Sipai Health Technology (00314) repurchased 591,400 ordinary shares on the Hong Kong Stock Exchange, amounting to 0.08% of its previously issued shares. The highest and lowest repurchase prices were HKD2.5 and HKD2.37 per share, respectively, for a total payment of HKD1,446,656. The volume-weighted average price stated in the announcement was HKD2.4462.
Following this transaction, the number of shares excluding treasury shares decreased to 738,824,114, while treasury shares rose to 26,754,000. The total issued shares remained 765,578,114. The repurchase was executed under a mandate dated 20 June 2025, with a moratorium period on new share issuance or sale/transfer of treasury shares continuing through 7 March 2026.